METABOLIC ANALYSIS OF GLIOBLASTOMA XENOGRAFTS AFTER ANTI-ANGIOGENIC TREATMENT

被引:0
|
作者
Fack, F. [1 ]
Zheng, L. [2 ]
Frezza, C. [2 ]
Keunen, O. [1 ]
Kalna, G. [2 ]
Nazarov, P. [3 ]
Gottlieb, E. [2 ]
Niclou, S. P. [1 ]
Bjerkvig, R. [1 ,4 ]
机构
[1] CRP Sante, NorLux Neurooncol Lab, Luxembourg, Luxembourg
[2] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland
[3] CRP Sante, Microarray Ctr, Luxembourg, Luxembourg
[4] Univ Bergen, Bergen, Norway
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:58 / 58
页数:1
相关论文
共 50 条
  • [41] Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme
    Soda, Yasushi
    Myskiw, Chad
    Rommel, Amy
    Verma, Inder M.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2013, 91 (04): : 439 - 448
  • [42] Metabolic changes and anti-tumor effects of a ketogenic diet combined with anti-angiogenic therapy in a glioblastoma mouse model
    Masahiro Maeyama
    Kazuhiro Tanaka
    Masamitsu Nishihara
    Yasuhiro Irino
    Masakazu Shinohara
    Hiroaki Nagashima
    Hirotomo Tanaka
    Satoshi Nakamizo
    Mitsuru Hashiguchi
    Yuichi Fujita
    Masaaki Kohta
    Eiji Kohmura
    Takashi Sasayama
    Scientific Reports, 11
  • [43] METABOLIC IMPACT OF ANTI-ANGIOGENIC AGENTS ON GLIOMA CELLS
    Mesti, T.
    Savarin, P.
    Triba, M. N.
    Ocvirk, J.
    Banissi, C.
    Carpentier, A. F.
    NEURO-ONCOLOGY, 2014, 16
  • [44] ANTI-ANGIOGENIC ISOFORMS OF VEGF - A KEY TO ANTI-ANGIOGENIC THERAPY
    Bates, D. O.
    Harper, S. J.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3207 - 3208
  • [45] Metabolic changes and anti-tumor effects of a ketogenic diet combined with anti-angiogenic therapy in a glioblastoma mouse model
    Maeyama, Masahiro
    Tanaka, Kazuhiro
    Nishihara, Masamitsu
    Irino, Yasuhiro
    Shinohara, Masakazu
    Nagashima, Hiroaki
    Tanaka, Hirotomo
    Nakamizo, Satoshi
    Hashiguchi, Mitsuru
    Fujita, Yuichi
    Kohta, Masaaki
    Kohmura, Eiji
    Sasayama, Takashi
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [46] Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles
    Sousa, Flavia
    Dhaliwal, Harkiranpreet Kaur
    Gattacceca, Florence
    Sarmento, Bruno
    Amiji, Mansoor M.
    JOURNAL OF CONTROLLED RELEASE, 2019, 309 (37-47) : 37 - 47
  • [47] Exploring the origin of the cancer stem cell niche and its role in anti-angiogenic treatment for glioblastoma
    Akindona, Funto A.
    Frederico, Stephen C.
    Hancock, John C.
    Gilbert, Mark R.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Relative cerebral blood volume as response predictor in the treatment of recurrent glioblastoma with anti-angiogenic therapy
    Breda-Yepes, Michele
    Rodriguez-Hernandez, Luis A.
    Gomez-Figueroa, Enrique
    Mondragon-Soto, Michel G.
    Arellano-Flores, Gerardo
    Hernandez-Hernandez, Alan
    Rodriguez-Rubio, Hector A.
    Martinez, Pablo
    Reyes-Moreno, Ignacio
    Alvaro-Heredia, Juan A.
    Aceves, Guillermo A. Gutierrez
    Villanueva-Castro, Eliezer
    Sangrador-Deitos, Marcos, V
    Alonso-Vanegas, Mario
    Guerrero-Juarez, Vicente
    Gonzalez-Aguilar, Alberto
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 233
  • [49] Anti-angiogenic treatment strategies for the therapy of endometriosis
    Laschke, M. W.
    Menger, M. D.
    HUMAN REPRODUCTION UPDATE, 2012, 18 (06) : 682 - 702
  • [50] Anti-angiogenic treatment of endometriosis: Biochemical aspects
    Taylor, RN
    Mueller, MD
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2004, 57 (01) : 54 - 56